日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ITGB1 Regulates Triple-Negative Breast Cancer Development by Modulating the Tumor Microenvironment

ITGB1通过调节肿瘤微环境来调控三阴性乳腺癌的发展

Song, Nuozi; Chen, Siqi; Wang, Lei; Dang, Jessica; Cao, Xu; Singh, Stephanie; Yang, Lu; Wang, Jinhui; Rosen, Steven T; Wang, Yingyu; Chen, Chun-Wei D; Zhang, Cheng; Feng, Mingye

T-Cell Receptor Clonotypes and Aggressive Subtypes in Cutaneous T-Cell Lymphoma

皮肤T细胞淋巴瘤的T细胞受体克隆型和侵袭性亚型

Crisan, Liliana L; Li, Shanpeng J; Afkhami, Michelle; Zain, Jasmine; Rosen, Steven T; Pillai, Raju; Querfeld, Christiane

Mogamulizumab-associated lymphadenopathy masquerading as lymphoma progression

莫加莫利珠单抗相关性淋巴结病伪装成淋巴瘤进展

Tizro, Parastou; Crisan, Liliana; Gaal, Karl; Rosen, Steven T; Zain, Jasmine; Querfeld, Christiane

Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review

妊娠期急性白血病:单中心23例病例(2012-2022年)的经验及文献综述

Liu, Wei; Guo, Jiamin; Gai, Dongzheng; Zhang, Kai-Xuan; Liu, Yi; Zhao, Xie-Lan; Fu, Xiao; Rosen, Steven T; Chen, Cong; Chen, Fangping

DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistance.

DDX6 发生相分离,从而调节代谢可塑性和化学耐药性。

Bi Hongjie, Li Wei, Ren Lili, Zhang Honghai, Dong Lei, Chan Anthony, Wang Xueer, Yang Lu, Zhang Xiaoxu, Xue Meilin, Qin Hanjun, Wu Xiwei, Hoeve-Scott Johanna Ten, Zhang Bin, Li Ling, Wunderlich Mark, Mulloy James C, Rosen Steven T, Chen Jianjun, Li Xiaobo, Chen Chun-Wei, Su Rui

CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation.

具有内置 CD47 阻断剂的 CAR 巨噬细胞可对抗肿瘤抗原异质性,并通过交叉呈递激活 T 细胞

Chen Siqi, Wang Yingyu, Dang Jessica, Song Nuozi, Chen Xiaoxin, Wang Jinhui, Huang Guo N, Brown Christine E, Yu Jianhua, Weissman Irving L, Rosen Steven T, Feng Mingye

Treatment-related adverse events of chimeric antigen receptor-T therapies for cancers in clinical trials: a systematic review and meta-analysis

嵌合抗原受体T细胞疗法治疗癌症临床试验中与治疗相关的不良事件:系统评价和荟萃分析

Zhu, Youwen; Liu, Kun; Rosen, Steven T; Liu, Wei; Zhu, Hong

Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1.

利用有机核心高密度脂蛋白样纳米颗粒封装和递送激酶抑制剂PIK-75靶向清道夫受体B类1型

Rink Jonathan S, Lin Adam Y, Calvert Andrea E, Kwon David, Moxley Alexandra, Henrich Stephen E, Mohammadlou Aliakbar, Zhang Xu Hannah, Wu Xiwei, Querfeld Christiane, Griend Donald J Vander, Yin Hongwei Holly, Horne David A, Nguyen SonBinh T, Rosen Steven T, Gordon Leo I, Thaxton Colby Shad

Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma

阿特珠单抗联合免疫原性挽救性化疗免疫疗法治疗转化型弥漫性大B细胞淋巴瘤患者

Othman, Tamer; Frankel, Paul; Allen, Pamela; Popplewell, Leslie L; Shouse, Geoffrey; Siddiqi, Tanya; Danilov, Alexey V; Ruel, Nora; Daniels, Shari; Peters, Lacolle; Khoo, Stella; Rosen, Steven T; Sharon, Elad; Villalona-Calero, Miguel; Ruel, Christopher; Tuscano, Joseph; Herrera, Alex F

Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma

度伐利尤单抗(抗PD-L1)联合来那度胺治疗复发/难治性皮肤T细胞淋巴瘤的I期临床试验

Querfeld, Christiane; Palmer, Joycelynne; Han, Zhen; Wu, Xiwei; Yuan, Yate-Ching; Chen, Min-Hsuan; Su, Chingyu; Tsai, Ni-Chun; Smith, D Lynne; Hammond, Samantha N; Crisan, Liliana; Song, Joo Y; Pillai, Raju; Rosen, Steven T; Zain, Jasmine